Memantine and depressed level of consciousness Patient Reports February 12, 2012
Memantine Side Effects Report #5273268-X
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Mar 06, 2007. Male patient, 92 years of age, weighting 128.1 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral infarction, depressed level of consciousness, fall
. Memantine dosage: unknown. During the same period patient was treated with PITAVASTATIN CALCIUM, NICERGOLINE, DENOPAMINE, DIGESTIVE ENZYME PREPARATIONS, FAMOTIDINE, CITICOLINE, CYANOCOBALAMIN, THIAMINE DISULFIDE NITRATE. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5150743-X
Memantine side effect was reported by a Health Professional from JAPAN on Oct 31, 2006. Male patient, 92 years of age, weighting 128.1 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral infarction, depressed level of consciousness, fall
, gait disturbance, restlessness, somnolence. Memantine dosage: unknown. During the same period patient was treated with PITAVASTATIN CALCIUM, NICERGOLINE, DENOPAMINE, DIGESTIVE ENZYME PREPARATIONS, FAMOTIDINE, CITICOLINE, CYANOCOBALAMIN, THIAMINE DISULFIDE NITRATE. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #4669224-2
Memantine side effect was reported by a Health Professional from on May 03, 2005. Female patient, 86 years of age, weighting 99.21 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: acute myocardial infarction, depressed level of consciousness, hypertension, urinary tract infection
. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DOXAZOSIN, FUROSEMIDE, ACETYLSALICYLIC ACID, CALCIFEROL. Patient was hospitalized. Patient died on 05/03/2005.Memantine Side Effects Report #4701542-1
Memantine side effect was reported by a Consumer or non-health professional from on June 16, 2005. Female patient, 86 years of age, weighting 99.21 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: depressed level of consciousness, hypertension, myocardial infarction, urinary tract infection
. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DOXAZOXIN, FUROSEMIDE, ASPIRIN, CALCIFEROL. Patient was hospitalized. Patient died on 05/03/2005.Memantine Side Effects Report #5050512-5
Memantine side effect was reported by a Consumer or non-health professional from SWEDEN on June 16, 2006. Female patient, 85 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: cardiac failure acute, depressed level of consciousness, respiratory depression. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ALVEDON, PEVARYL, ENALAPRIL ACTAVIS, FOLACIN, WARFARIN, BEHEPAN, DIGOXIN, KALUM RETARD. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5246154-9
Memantine side effect was reported by a Health Professional from JAPAN on Feb 08, 2007. Male patient, 80 years of age, weighting 87.96 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, c-reactive protein increased, depressed level of consciousness. Memantine dosage: unknown. During the same period patient was treated with CERNITIN POLLEN, TAMSULOSIN, MAGNESIUM OXIDE, EPINASTINE HYDROCHLORIDE, CROTAMITON. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5306746-5
Memantine side effect was reported by a Health Professional from JAPAN on Apr 09, 2007. Male patient, 80 years of age, weighting 87.96 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, decubitus ulcer, depressed level of consciousness, white blood cell count increased. Memantine dosage: unknown. During the same period patient was treated with CERNITIN POLLEN, TAMSULOSIN, MAGNESIUM OXIDE, EPINASTINE HYDROCHLORIDE, CROTAMITON. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5310147-3
Memantine side effect was reported by a Health Professional from JAPAN on Apr 12, 2007. Male patient, 80 years of age, weighting 87.96 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood pressure decreased, blood pressure systolic decreased, decubitus ulcer, depressed level of consciousness, productive cough. Memantine dosage: unknown. During the same period patient was treated with CERNITIN POLLEN, TAMSULOSIN, MAGNESIUM OXIDE, EPINASTINE HYDROCHLORIDE, CROTAMITON. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5892179-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Sept 10, 2008. Male patient, 80 years of age, was diagnosed with dementia alzheimer's type, urinary retention and was treated with Memantine. After drug was administered, patient experienced the following side effects: apnoea, blood pressure increased, cerebral amyloid angiopathy, cerebral haemorrhage, cholinergic syndrome, convulsion, depressed level of consciousness, diarrhoea, haemorrhage subcutaneous. Memantine dosage: 20 MG (20 MG,ONCE DAILY AFTER BREAKFAST, ORAL; 20 MG (20 MG,ONCE DAILY AFTER BREAKFAST), ORAL. During the same period patient was treated with DISTIGIMINE BROMIDE, DISTIGIMINE BROMIDE, PIRENOXINE, PRANOPROFEN, NIFEDIPINE, ASPIRIN, MAGNESIUM HYDROXIDE. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4592635-0
Memantine side effect was reported by a Health Professional from on Feb 07, 2005. Male patient, 78 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: depressed level of consciousness, stupor. Memantine dosage: 5 MG QD PO. During the same period patient was treated with DETROL, CARDIZEM. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4897081-8
Memantine side effect was reported by a Pharmacist from UNITED KINGDOM on Jan 18, 2006. Male patient, 76 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: depressed level of consciousness, malaise, myoclonus. Memantine dosage: 5 MG BID, PO. During the same period patient was treated with GALANTAMINE, SENNA. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #5121923-4
Memantine side effect was reported by a Health Professional from BELGIUM on Sept 04, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood glucose increased, blood uric acid decreased, cognitive disorder, depressed level of consciousness, diabetes mellitus inadequate control, disorientation, disturbance in social behaviour, dizziness
, glycosylated haemoglobin increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with LACRYSTAT, PRANOX, ACETYLSALICYLIC ACID SRT, PERSANTINE, CITALOPRAM HYDROBROMIDE, TRAZOLAN, PANTOPRAZOLE, DIAMICRON. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5173225-8
Memantine side effect was reported by a Health Professional from BELGIUM on Nov 27, 2006. Male patient, 75 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abnormal behaviour, aggression, agitation, blood glucose increased, cholecystitis acute, depressed level of consciousness, gait disturbance, glabellar reflex abnormal, glycosylated haemoglobin increased. Memantine dosage: 10 MG BID PO. During the same period patient was treated with LACRYSTAT, PRANOX, ACETYLSALICYLIC ACID SRT, PERSANTINE, CITALOPRAM HYDROBROMIDE, TRAZOLAM, PANTOZOL, DIAMICRON. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4724496-0
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on July 08, 2005. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood pressure increased, blood urea increased, body temperature increased, cholangitis, cholecystitis, cholelithiasis, depressed level of consciousness, grip strength decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM. Patient was hospitalized. Patient recovered.
Memantine Side Effects Report #4979558-X
Memantine side effect was reported by a Health Professional from FRANCE on Apr 03, 2006. Male patient, 73 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: depressed level of consciousness, fall
, overdose. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, SECTRAL, COVERSYL, LASIX, CORVASAL, KARDEGIC. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #4984241-0
Memantine side effect was reported by a Consumer or non-health professional from FRANCE on Apr 18, 2006. Male patient, 73 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: depressed level of consciousness, fall
, overdose. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, SECTRAL, COVERSYL, LASIX, CORVASAL, KARDEGIC. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5120003-1
Memantine side effect was reported by a Health Professional from JAPAN on Sept 22, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: anaemia, blood calcium decreased, blood cholinesterase decreased, blood glucose increased, blood potassium decreased, blood sodium decreased, cough, depressed level of consciousness, diffuse large b-cell lymphoma stage iv. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.
Memantine Side Effects Report #4913550-6
Memantine side effect was reported by a Health Professional from SPAIN on Jan 26, 2006. Male patient, 74 years of age, was diagnosed with cognitive deterioration, dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: agitation, cerebral atrophy, condition aggravated, dementia
, depressed level of consciousness, hallucination, visual, parkinsonism. Memantine dosage: 5 MG QD. During the same period patient was treated with RISPERIDONE, DONEPEZIL, RIVASTIGMINE, ENALAPRIL MALEATE. Patient recovered.Memantine Side Effects Report #5650223-9
Memantine side effect was reported by a Health Professional from FRANCE on Feb 12, 2008. Male patient, 77 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: aspiration, brain scan abnormal, cerebral atrophy, coma, convulsion, depressed level of consciousness, disorientation, dyskinesia, electrocardiogram abnormal. Memantine dosage: 20 MG QD;PO. During the same period patient was treated with MIRTAZAPINE, MEPROBAMATE, MODOPAR, THEOSTAT, ZOCOR, PLAVIX. Patient was hospitalized. Patient died on 11/08/2007.
Memantine Side Effects Report #4596595-8
Memantine side effect was reported by a Physician from on Feb 09, 2005. Female patient, 72 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: cerebral atrophy, cerebral ischaemia, confusional state, creatinine renal clearance decreased, depressed level of consciousness, electroencephalogram abnormal, fall
, grand mal convulsion, headache
. Memantine dosage: 15 MG QD PO. During the same period patient was treated with LATANOPROST, AMLODIPINE BESYLATE, VITAMIN B CAP, VITAMIN E, ASPIRIN. Patient was hospitalized. Patient recovered.Memantine Side Effects Report #5782003-8
Memantine side effect was reported by a Pharmacist from GERMANY on June 13, 2008. Female patient, child 4 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: blood creatinine increased, depressed level of consciousness, disturbance in attention, electroencephalogram abnormal, encephalitis
, eosinophil percentage decreased, gait disturbance. Memantine dosage: unknown. During the same period patient was treated with CAPTOPRIL. Patient was hospitalized. Patient recovered.
Memantine and depressed level of consciousness 